The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Muromegalovirus


Psychiatry related information on Muromegalovirus


High impact information on Muromegalovirus


Chemical compound and disease context of Muromegalovirus


Biological context of Muromegalovirus


Anatomical context of Muromegalovirus


Gene context of Muromegalovirus


Analytical, diagnostic and therapeutic context of Muromegalovirus


  1. Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus. Fleck, M., Kern, E.R., Zhou, T., Podlech, J., Wintersberger, W., Edwards, C.K., Mountz, J.D. J. Clin. Invest. (1998) [Pubmed]
  2. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. Salazar-Mather, T.P., Ishikawa, R., Biron, C.A. J. Immunol. (1996) [Pubmed]
  3. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules. Hengel, H., Burke, K., Kyburz, D., Zinkernagel, R.M., Koszinowski, U.H. J. Immunol. (1995) [Pubmed]
  4. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Schreiber, M., Muller, W.J., Singh, G., Graham, F.L. Oncogene (1999) [Pubmed]
  5. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity. Wagner, M., Michel, D., Schaarschmidt, P., Vaida, B., Jonjic, S., Messerle, M., Mertens, T., Koszinowski, U. J. Virol. (2000) [Pubmed]
  6. Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity. Selgrade, M.K., Daniels, M.J., Hu, P.C., Miller, F.J., Graham, J.A. Infect. Immun. (1982) [Pubmed]
  7. Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Quinnan, G.V., Manischewitz, J.E., Ennis, F.A. Nature (1978) [Pubmed]
  8. Reactivation of murine cytomegalovirus by cyclophosphamide. Mayo, D.R., Armstrong, J.A., Ho, M. Nature (1977) [Pubmed]
  9. TRAIL-R as a negative regulator of innate immune cell responses. Diehl, G.E., Yue, H.H., Hsieh, K., Kuang, A.A., Ho, M., Morici, L.A., Lenz, L.L., Cado, D., Riley, L.W., Winoto, A. Immunity (2004) [Pubmed]
  10. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Ziegler, H., Thale, R., Lucin, P., Muranyi, W., Flohr, T., Hengel, H., Farrell, H., Rawlinson, W., Koszinowski, U.H. Immunity (1997) [Pubmed]
  11. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Tabeta, K., Hoebe, K., Janssen, E.M., Du, X., Georgel, P., Crozat, K., Mudd, S., Mann, N., Sovath, S., Goode, J., Shamel, L., Herskovits, A.A., Portnoy, D.A., Cooke, M., Tarantino, L.M., Wiltshire, T., Steinberg, B.E., Grinstein, S., Beutler, B. Nat. Immunol. (2006) [Pubmed]
  12. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. Ruzek, M.C., Miller, A.H., Opal, S.M., Pearce, B.D., Biron, C.A. J. Exp. Med. (1997) [Pubmed]
  13. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. Ziegler, H., Muranyi, W., Burgert, H.G., Kremmer, E., Koszinowski, U.H. EMBO J. (2000) [Pubmed]
  14. Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Uprichard, S.L., Wieland, S.F., Althage, A., Chisari, F.V. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  15. Leukotriene B4 protects latently infected mice against murine cytomegalovirus reactivation following allogeneic transplantation. Gosselin, J., Borgeat, P., Flamand, L. J. Immunol. (2005) [Pubmed]
  16. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. Reddehase, M.J., Keil, G.M., Koszinowski, U.H. J. Immunol. (1984) [Pubmed]
  17. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. Lee, S.H., Zafer, A., de Repentigny, Y., Kothary, R., Tremblay, M.L., Gros, P., Duplay, P., Webb, J.R., Vidal, S.M. J. Exp. Med. (2003) [Pubmed]
  18. Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. McVoy, M.A., Nixon, D.E., Adler, S.P., Mocarski, E.S. J. Virol. (1998) [Pubmed]
  19. Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression. García-Ramírez, J.J., Ruchti, F., Huang, H., Simmen, K., Angulo, A., Ghazal, P. J. Virol. (2001) [Pubmed]
  20. Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression. Campbell, A.E., Slater, J.S. J. Virol. (1994) [Pubmed]
  21. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. Krmpotic, A., Hasan, M., Loewendorf, A., Saulig, T., Halenius, A., Lenac, T., Polic, B., Bubic, I., Kriegeskorte, A., Pernjak-Pugel, E., Messerle, M., Hengel, H., Busch, D.H., Koszinowski, U.H., Jonjic, S. J. Exp. Med. (2005) [Pubmed]
  22. A novel checkpoint in the Bcl-2-regulated apoptotic pathway revealed by murine cytomegalovirus infection of dendritic cells. Andoniou, C.E., Andrews, D.M., Manzur, M., Ricciardi-Castagnoli, P., Degli-Esposti, M.A. J. Cell Biol. (2004) [Pubmed]
  23. Murine cytomegalovirus paralyzes macrophages by blocking IFN gamma-induced promoter assembly. Popkin, D.L., Watson, M.A., Karaskov, E., Dunn, G.P., Bremner, R., Virgin, H.W. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  24. Adoptive transfer of anti-cytomegalovirus effect of interleukin-2-activated bone marrow: potential application in transplantation. Agah, R., Charak, B.S., Chen, V., Mazumder, A. Blood (1991) [Pubmed]
  25. Fas-mediated apoptosis of the hematopoietic progenitor cells in mice infected with murine cytomegalovirus. Mori, T., Ando, K., Tanaka, K., Ikeda, Y., Koga, Y. Blood (1997) [Pubmed]
  26. Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice. Zhang, H.G., Fleck, M., Kern, E.R., Liu, D., Wang, Y., Hsu, H.C., Yang, P., Wang, Z., Curiel, D.T., Zhou, T., Mountz, J.D. J. Clin. Invest. (2000) [Pubmed]
  27. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. Strobl, B., Bubic, I., Bruns, U., Steinborn, R., Lajko, R., Kolbe, T., Karaghiosoff, M., Kalinke, U., Jonjic, S., Müller, M. J. Immunol. (2005) [Pubmed]
  28. The r144 major histocompatibility complex class I-like gene of rat cytomegalovirus is dispensable for both acute and long-term infection in the immunocompromised host. Beisser, P.S., Kloover, J.S., Grauls, G.E., Blok, M.J., Bruggeman, C.A., Vink, C. J. Virol. (2000) [Pubmed]
  29. Role of chemokines in the biology of natural killer cells. Robertson, M.J. J. Leukoc. Biol. (2002) [Pubmed]
  30. Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets. Depatie, C., Chalifour, A., Paré, C., Lee, S.H., Vidal, S.M., Lemieux, S. Int. Immunol. (1999) [Pubmed]
  31. Size of infectious DNA from human and murine cytomegaloviruses. Lakeman, A.D., Osborn, J.E. J. Virol. (1979) [Pubmed]
  32. Systemic cytokine immunotherapy for experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency. Dix, R.D., Giedlin, M., Cousins, S.W. Invest. Ophthalmol. Vis. Sci. (1997) [Pubmed]
  33. Potentiation of murine cytomegalovirus pneumonitis by antibiotics in clinical use. Olver, S.D., Price, P., Karthigasu, K.T. J. Antimicrob. Chemother. (1991) [Pubmed]
  34. Cloning and sequence analysis of the genes encoding DNA polymerase, glycoprotein B, ICP18.5 and major DNA-binding protein of rat cytomegalovirus. Beuken, E., Slobbe, R., Bruggeman, C.A., Vink, C. J. Gen. Virol. (1996) [Pubmed]
WikiGenes - Universities